Norway
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
5.55%
|
Dec. 31, 2023 | USD 5.25 | 2.05% |
|
Norway |
|
2 |
4.61%
|
Dec. 31, 2023 | USD 2.21 | -0.65% |
|
Norway |
|
3 |
-9.37%
|
Dec. 31, 2023 | USD 4.31 | 4.92% |
|
Norway |
|
4 |
-270.12%
|
Dec. 31, 2023 | USD 1.13 | -2.55% |
|
Norway |
|
5 |
-743.85%
|
Dec. 31, 2023 | USD 0.11 | -0.62% |
|
Norway |
|
6 |
-54,186.16%
|
Dec. 31, 2023 | USD 0.73 | 3.02% |
|
Norway |
The Pharmaceuticals company in Norway with the highest Operating Income Margin is Photocure ASA (Oslo Stock Exchange: PHO.OL) at 5.55%.
The Pharmaceuticals company in Norway with the lowest Operating Income Margin is BerGenBio ASA (Oslo Stock Exchange: BGBIO.OL) at -54,186.16%.
The top 10 Pharmaceuticals companies in Norway by Operating Income Margin are Photocure ASA, Navamedic ASA, Gentian Diagnostics ASA, Lifecare AS, PCI Biotech Holding ASA and BerGenBio ASA.
The bottom 10 Pharmaceuticals companies in Norway by Operating Income Margin are BerGenBio ASA, PCI Biotech Holding ASA, Lifecare AS, Gentian Diagnostics ASA, Navamedic ASA and Photocure ASA.